Evidence map›Paper›PMID 35279094›Full record

ArticleBMC infectious diseases2022

Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children.

Hossein Esmaeilzadeh, Anahita Sanaei Dashti, Negar Mortazavi, Hossein Fatemian, Mohebat Vali

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Long COVID in Children: A Multidisciplinary Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  13. Post-COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration.Journal of clinical pathways : the foundation of value-based care · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hossein EsmaeilzadehAllergy Research Center, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran. esmailzadeh_ho@yahoo.com.
Anahita Sanaei DashtiAlborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Negar MortazaviDepartment of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran. mortazavi_ne@yahoo.com.ORCID http://orcid.org/0000-0003-3487-2192
Hossein FatemianAllergy Research Center, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran.
Mohebat ValiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsRespiratory viruses are the main triggers of asthma. Coronavirus is shown to contribute to respiratory tract infections that can lead to prolonged cough and asthma.

objectivesPresent study aimed to determine the risk of developing Persistent cough and asthma-like symptoms in hospitalized children due to COVID-19.

methodsThis prospective study was carried out in a tertiary referral center. During the COVID-19 pandemic, 69 hospitalized pediatric patients admitted with COVID-19 were observed from February 2020 to January 2021. Clinical and laboratory data were recorded, and after discharge, patients were followed and visited for cough and asthma evaluation one, 2 and 6 months later. Patients with asthma-like diagnoses in follow up defined as asthma-like groups, and patients without any sign of asthma were categorized as the non-asthma group. Asthma-like co-morbids and risk factors were evaluated and compared between the two groups.

resultsIn follow-up, most of the COVID-19 hospitalized patients (N = 42) (58.5%) were not affected by asthma-like symptoms. 60.9% of the COVID-19 patients were male. The asthma-like group cases had a significantly familial history of asthma (63.0%), past medical history of asthma (33.3%), and Allergic rhinitis (85.2%). Rates of signs and symptoms during hospitalization were significantly higher in patients with COVID-19 and past medical history of asthma.

conclusionsWe found an asthma-like prevalence of 41.5% in the cohort of COVID-19 hospitalized children. Family history of asthma and previous history of asthma and allergic rhinitis are risk factors for asthma-like after COVID-19 hospitalization. COVID-19 presentations are more severe in the asthma-like group.

Indexed as

AsthmaCOVID-19ChildCoughHospitalizationHumansMalePandemicsProspective StudiesSARS-CoV-2AsthmaChildCOVID-19Hospitalization

Identifiers

PMID35279094
PMCPMC8917254
OpenAlexW4220905249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.